Senior insider sale
Executive Vice President at AMNEAL PHARMACEUTICALS, INC. — senior position signals high conviction
$3.41M
324.38K shares
SHAH NIKITA plans to sell 324.38K shares of AMNEAL PHARMACEUTICALS, INC. valued at approximately $3.41M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
STOCK OPTION EXERCISE
STOCK OPTION EXERCISE
STOCK OPTION EXERCISE
STOCK OPTION EXERCISE
STOCK OPTION EXERCISE
STOCK OPTION EXERCISE
STOCK OPTION EXERCISE
STOCK OPTION EXERCISE
STOCK OPTION EXERCISE
STOCK OPTION EXERCISE
STOCK OPTION EXERCISE
STOCK OPTION EXERCISE
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/1/2023 | STOCK OPTION EXERCISE STOCK OPTION EXERCISE | 23.88K | — |
5/7/2022 | STOCK OPTION EXERCISE STOCK OPTION EXERCISE | 18.17K | — |
3/1/2022 | STOCK OPTION EXERCISE STOCK OPTION EXERCISE | 23.88K | — |
5/7/2021 | STOCK OPTION EXERCISE STOCK OPTION EXERCISE | 18.16K | — |
3/1/2021 | STOCK OPTION EXERCISE STOCK OPTION EXERCISE | 23.88K | — |
3/1/2020 | STOCK OPTION EXERCISE STOCK OPTION EXERCISE | 23.88K | — |
| Total | 131.86K | ||
Completed
Units to sell
36.80K
Market value
$356.9K
Units to sell
84.04K
Market value
$818.9K
Units to sell
71.69K
Market value
$663.1K
Planned — Approximate Date
Units to sell
131.86K
Market value
$1.57M
Units
324.38K
Value
$3.41M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
8/22/2025 | 36.80K | $356.9K | — | Completed |
8/22/2025 | 84.04K | $818.9K | — | Completed |
8/14/2025 | 71.69K | $663.1K | — | Completed |
| Planned — Approximate Date | ||||
11/12/2025 | 131.86K | $1.57M | NASDAQ | Planned |
| Total | 324.38K | $3.41M | ||